Table 1 Seropositivity of NT antibody to EV71 and/or CA16 by age groups
Age | N | % seropositive | ||
|---|---|---|---|---|
+ve both EV71 and CA16 | +ve EV71 only | +ve CA16 only | ||
< 6 m | 30 | 33.3 | 6.7 | 33.3 |
6–11 m | 55 | 0.0 | 5.5 | 16.4 |
1 y | 110 | 0.9 | 11.8 | 20.0 |
2 y | 65 | 16.9 | 23.1 | 21.5 |
3 y | 58 | 27.6 | 19.0 | 20.7 |
4 y | 31 | 41.9 | 22.6 | 29.0 |
5–6 y | 43 | 67.4 | 9.3 | 20.9 |
7–11 y | 72 | 80.6 | 5.6 | 12.5 |
12–17 y | 61 | 86.9 | 3.3 | 8.2 |
≥18 y | 54 | 74.1 | 3.7 | 22.2 |
Total (All age groups) | 579 | 39.9 | 10.9 | 19.2 |